Final results of Phase 2 clinical trials show Jusvinza effectively treats post-acute and chronic Chikungunya symptoms
The final results of the Phase 2 clinical trials for Jusvinza treatment in patients recovering from Chikungunya, both in the post-acute and chronic stages of the disease, confirmed the hypothesis posed by the researchers: “It resolved the painful and inflammatory joint symptoms caused by this virus.”
Cuban Government Announces Decision to Grant Pardons to More Than 2,000 Prisoners
As part of the process of granting penitentiary benefits established by law, and in accordance with Article 90, subsection II of the Constitution of the Republic, the decision was made to release 2,010 convicted individuals through a pardon approved by the Cuban government.
This humanitarian and sovereign gesture followed a careful analysis of the nature of the crimes committed, the good behavior maintained in prison, the completion of a significant portion of the sentence, and the health status of those involved.
Science magazine highlights the impact of the U.S. embargo on Cuba’s science and health sectors
A recent article published by Science warns of the growing pressure faced by hospitals, research centers, and laboratories in Cuba due to a combination of critical factors. The publication notes that the U.S. embargo, combined with fuel shortages, prolonged blackouts, and logistical challenges, is severely affecting the island’s healthcare system and scientific activity.




